Research on the Clinical Value of Cranial CT and CTA for Cerebral Hemorrhage Patients

Research on the Clinical Value of Cranial CT and CTA in Patients With Cerebral Hemorrhage

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07100132

Enrollment

300

Registered

2025-08-03

Start date

2025-10-01

Completion date

2027-06-01

Last updated

2025-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage (ICH)

Brief summary

The objective of this observational study is to investigate the predictive value of various imaging signs in patients with intracerebral hemorrhage, thereby providing a reference for clinical diagnosis and treatment. The primary aim is to evaluate the association between specific imaging signs and both hematoma expansion and poor outcomes in these patients.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

(1) Patients who were confirmed to have cerebral hemorrhage through head CT imaging examination upon admission; (2) Those who completed head CT and CTA within 8 hours of onset and had a follow-up CT within 24 hours of admission; (3) With complete clinical data.

Exclusion criteria

(1) Patients who cannot complete CT and CTA within the prescribed time; (2) Patients with secondary cerebral hemorrhage due to cerebral vascular malformations, brain tumors, brain trauma, cerebral aneurysms, etc.; (3) Patients who have been taking oral anticoagulants for a long time or have blood system diseases; (4) Primary intraventricular hemorrhage.

Design outcomes

Primary

Measure	Time frame
Randomized 180-day mRS score of 0-3 (%)	From the end of the six-month period after discharge.

Contacts

Primary ContactQian Wu

596914581@qq.com18586876127

Outcome results